|Articles|November 1, 2011

Study: Vitamin B5 Ingredient Lowers LDL Cholesterol

Pantesin, a highly absorbable vitamin B5 (pantethine) from Kyowa Hakko (New York City), may significantly lower low-density lipoprotein (LDL) cholesterol in humans, according to research published in the journal Nutrition Research.

Pantesin, a highly absorbable vitamin B5 (pantethine) from Kyowa Hakko (New York City), may significantly lower low-density lipoprotein (LDL) cholesterol in humans, according to research published in the journal Nutrition Research.

For 16 weeks, 120 participants with low to moderate risk of heart disease were assigned to 600 mg of Pantesin or an equivalent placebo daily. By the end of the study, the Pantesin group experienced an average 4 mg/dL reduction of LDL cholesterol compared to the placebo group.

While such a change may seem small at plain sight, the researchers noted that “for each 1 mg reduction in LDL cholesterol, there is a concomitant 1% reduction in overall future cardiovascular disease risk.”


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.